Chet R. Villa

Chet R. Villa

Auto-generated profile, based on publicly available information

Chet R. Villa

Cincinnati Children's Hospital Medical Center University of Cincinnati College of Medicine Cincinnati USA

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2017 in Pediatric Transplantation
Verified
Journal Article
Closed access
PDF file
WCWaldemar F. Carlo
Waldemar F. Carlo
CVChet R. Villa
Chet R. Villa
ALAshwin K. Lal
Ashwin K. Lal
DMDavid L. Morales
David L. Morales

13 January 2022 in Pediatric Cardiology
Verified
Journal Article
Closed access
PDF file
CVChet Villa
Chet Villa
SAScott R. Auerbach
Scott R. Auerbach
NBNeha Bansal
Neha Bansal
BBBrian F. Birnbaum
Brian F. Birnbaum
JCJennifer Conway
Jennifer Conway
LCLinda Cripe
Linda Cripe

28 February 2023 in Circulation
Verified
Journal Article
Open access
PDF file
JCJennifer Conway
Jennifer Conway
SMSandar Min
Sandar Min
CVChet Villa
Chet Villa
RWRobert G. Weintraub
Robert G. Weintraub
SNStephanie Nakano
Stephanie Nakano
SMSeema Mital
Seema Mital
Background: Hypertrophic cardiomyopathy (HCM) can be associated with an abnormal exercise response. In adults with HCM, abnormal results on exercise stress testing are predictive of heart failure outcomes. Our goal was to determine whether an abnormal exercise response is associated with adverse outcomes in pediatric patients with HCM. Methods: In an international cohort study including 20 centers, phenotype-positive patients with primary HCM who were <18 years of age at diagnosis were included. Abnormal exercise response was defined as a blunted blood pressure response and new or worsened ST- or T-wave segment changes or complex ventricular ectopy. Sudden cardiac death (SCD) events were defined as a composite of SCD and aborted sudden cardiac arrest. Using Kaplan-Meier survival, competing outcomes, and Cox regression analyses, we analyzed the association of abnormal exercise test results with transplant and SCD event-free survival. Results: Of 724 eligible patients, 630 underwent at least 1 exercise test. There were no major differences in clinical characteristics between those with or without an exercise test. The median age at exercise testing was 13.8 years (interquartile range, 4.7 years); 78% were male and 39% were receiving beta-blockers. A total of 175 (28%) had abnormal test results. Patients with abnormal test results had more severe septal hypertrophy, higher left atrial diameter z scores, higher resting left ventricular outflow tract gradient, and higher frequency of myectomy compared with participants with normal test results ( P <0.05). Compared with normal test results, abnormal test results were independently associated with lower 5-year transplant-free survival (97% versus 88%, respectively; P =0.005). Patients with exercise-induced ischemia were most likely to experience all-cause death or transplant (hazard ratio, 4.86 [95% CI, 1.69–13.99]), followed by those with an abnormal blood pressure response (hazard ratio, 3.19 [95% CI, 1.32–7.71]). Exercise-induced ischemia was also independently associated with lower SCD event-free survival (hazard ratio, 3.32 [95% CI, 1.27–8.70]). Exercise-induced ectopy was not associated with survival. Conclusions: Exercise abnormalities are common in childhood HCM. An abnormal exercise test result was independently associated with lower transplant-free survival, especially in those with an ischemic or abnormal blood pressure response with exercise. Exercise-induced ischemia was also independently associated with SCD events. These findings argue for routine exercise testing in childhood HCM as part of ongoing risk assessment.

1 February 2021 in The Journal of Heart and Lung Transplantation
Verified
Journal Article
Closed access
NSNicholas A. Szugye
Nicholas A. Szugye
FZFarhan Zafar
Farhan Zafar
NONicholas J. Ollberding
Nicholas J. Ollberding
CVChet Villa
Chet Villa
ALAngela Lorts
Angela Lorts
RMRyan A. Moore
Ryan A. Moore

19 December 2015 in Pediatric Cardiology
Verified
Journal Article
Open access
PDF file
KAKonstantin Averin
Konstantin Averin
CVChet Villa
Chet Villa
CKCatherine D. Krawczeski
Catherine D. Krawczeski
JPJesse Pratt
Jesse Pratt
EKEileen King
Eileen King
ALAngela Lorts
Angela Lorts
Myocardial contractility and relaxation are highly dependent on calcium homeostasis. Immature myocardium, as in pediatric patients, is thought to be more dependent on extracellular calcium for optimal function. For this reason, intravenous calcium chloride infusions may improve myocardial function in the pediatric patient. The objectives of this study were to report the hemodynamic changes seen after administration of continuous calcium chloride to critically ill children. We retrospectively identified pediatric patients (newborn to 17 years old) with hemodynamic instability admitted to the cardiac ICU between May 2011 and May 2012 who received a continuous infusion of calcium chloride. The primary outcome was improvement in cardiac output, assessed by arterial-mixed venous oxygen saturation (A–V) difference. Sixty-eight patients, mean age 0.87 ± 2.67 years, received a total of 116 calcium infusions. Calcium chloride infusions resulted in significant improvements in primary and secondary measures of cardiac output at 2 and 6 h. Six hours after calcium initiation, A–V oxygen saturation difference decreased by 7.4 % (32.6 ± 2.1 to 25.2 ± 2.0 %, p < 0.001), rSO2 increased by 5.5 % (63.1 vs 68.6 %, p < 0.001), and serum lactate decreased by 0.9 mmol/l (3.3 vs 2.4 mmol/l, p < 0.001) with no change in HR (149.1 vs 145.6 bpm p = 0.07). Urine output increased 0.66 ml/kg/h in the 8-h period after calcium initiation when compared to pre-initiation (p = 0.003). Neonates had the strongest evidence of effectiveness with other age groups trending toward significance. Calcium chloride infusions improve markers of cardiac output in a heterogenous group of pediatric patients in a cardiac ICU. Neonates appear to derive the most benefit from utilization of these infusions.

1 October 2016 in Neuromuscular Disorders
Verified
Journal Article
Closed access
CVChet R. Villa
Chet R. Villa
AKAhmad Kaddourah
Ahmad Kaddourah
JMJacob Mathew
Jacob Mathew
TRThomas D. Ryan
Thomas D. Ryan
BWBrenda L. Wong
Brenda L. Wong
JJJohn L. Jefferies
John L. Jefferies